nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB1—ovarian cancer	0.21	1	CbGaD
Chlorpromazine—ABCB11—Paclitaxel—ovarian cancer	0.102	0.292	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—ovarian cancer	0.0551	0.158	CbGbCtD
Chlorpromazine—ABCB1—Topotecan—ovarian cancer	0.0354	0.101	CbGbCtD
Chlorpromazine—ABCB1—Vinorelbine—ovarian cancer	0.0249	0.0713	CbGbCtD
Chlorpromazine—CYP2D6—Vinorelbine—ovarian cancer	0.0235	0.0672	CbGbCtD
Chlorpromazine—CYP3A4—Topotecan—ovarian cancer	0.0212	0.0607	CbGbCtD
Chlorpromazine—ABCB1—Paclitaxel—ovarian cancer	0.0175	0.0501	CbGbCtD
Chlorpromazine—CYP3A4—Vinorelbine—ovarian cancer	0.0149	0.0427	CbGbCtD
Chlorpromazine—ABCB1—Docetaxel—ovarian cancer	0.0127	0.0362	CbGbCtD
Chlorpromazine—CYP3A4—Paclitaxel—ovarian cancer	0.0105	0.03	CbGbCtD
Chlorpromazine—ABCB1—Doxorubicin—ovarian cancer	0.00944	0.027	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—ovarian cancer	0.00889	0.0255	CbGbCtD
Chlorpromazine—BCHE—diaphragm—ovarian cancer	0.00816	0.0617	CbGeAlD
Chlorpromazine—CHRM3—muscle of abdomen—ovarian cancer	0.00801	0.0606	CbGeAlD
Chlorpromazine—CYP3A4—Docetaxel—ovarian cancer	0.00759	0.0217	CbGbCtD
Chlorpromazine—HTR7—vein—ovarian cancer	0.00588	0.0444	CbGeAlD
Chlorpromazine—CYP3A4—Doxorubicin—ovarian cancer	0.00565	0.0162	CbGbCtD
Chlorpromazine—CALM2—oviduct—ovarian cancer	0.00372	0.0281	CbGeAlD
Chlorpromazine—HTR2A—vein—ovarian cancer	0.00366	0.0277	CbGeAlD
Chlorpromazine—Ileus paralytic—Vinorelbine—ovarian cancer	0.00301	0.0237	CcSEcCtD
Chlorpromazine—HRH4—bone marrow—ovarian cancer	0.00298	0.0225	CbGeAlD
Chlorpromazine—Pancytopenia—Altretamine—ovarian cancer	0.00287	0.0226	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Paclitaxel—ovarian cancer	0.00262	0.0206	CcSEcCtD
Chlorpromazine—SMPD1—decidua—ovarian cancer	0.00242	0.0183	CbGeAlD
Chlorpromazine—Hypotensive—Paclitaxel—ovarian cancer	0.0024	0.0189	CcSEcCtD
Chlorpromazine—Hyperpyrexia—Paclitaxel—ovarian cancer	0.00235	0.0185	CcSEcCtD
Chlorpromazine—SMPD1—gonad—ovarian cancer	0.00213	0.0161	CbGeAlD
Chlorpromazine—Ileus paralytic—Paclitaxel—ovarian cancer	0.00203	0.0159	CcSEcCtD
Chlorpromazine—Amenorrhoea—Chlorambucil—ovarian cancer	0.00195	0.0153	CcSEcCtD
Chlorpromazine—SMPD1—female reproductive system—ovarian cancer	0.0019	0.0144	CbGeAlD
Chlorpromazine—Leukopenia—Altretamine—ovarian cancer	0.00188	0.0148	CcSEcCtD
Chlorpromazine—Convulsion—Altretamine—ovarian cancer	0.00182	0.0143	CcSEcCtD
Chlorpromazine—Dyskinesia—Chlorambucil—ovarian cancer	0.00182	0.0143	CcSEcCtD
Chlorpromazine—SMPD1—female gonad—ovarian cancer	0.00173	0.0131	CbGeAlD
Chlorpromazine—DRD4—testis—ovarian cancer	0.00173	0.0131	CbGeAlD
Chlorpromazine—SMPD1—vagina—ovarian cancer	0.00172	0.013	CbGeAlD
Chlorpromazine—Amenorrhoea—Melphalan—ovarian cancer	0.0017	0.0133	CcSEcCtD
Chlorpromazine—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.00158	0.0124	CcSEcCtD
Chlorpromazine—Endocrine disorder—Vinorelbine—ovarian cancer	0.00157	0.0124	CcSEcCtD
Chlorpromazine—SMPD1—testis—ovarian cancer	0.00154	0.0116	CbGeAlD
Chlorpromazine—CALM3—myometrium—ovarian cancer	0.00151	0.0114	CbGeAlD
Chlorpromazine—Pigmentation disorder—Epirubicin—ovarian cancer	0.0015	0.0118	CcSEcCtD
Chlorpromazine—DRD5—female reproductive system—ovarian cancer	0.00141	0.0107	CbGeAlD
Chlorpromazine—Pigmentation disorder—Doxorubicin—ovarian cancer	0.00139	0.0109	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00138	0.0108	CcSEcCtD
Chlorpromazine—HTR2B—myometrium—ovarian cancer	0.00135	0.0102	CbGeAlD
Chlorpromazine—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.00134	0.0105	CcSEcCtD
Chlorpromazine—Gait disturbance—Vinorelbine—ovarian cancer	0.00133	0.0105	CcSEcCtD
Chlorpromazine—DRD5—female gonad—ovarian cancer	0.00128	0.00971	CbGeAlD
Chlorpromazine—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00122	0.00962	CcSEcCtD
Chlorpromazine—ABCB11—testis—ovarian cancer	0.00122	0.00919	CbGeAlD
Chlorpromazine—Throat sore—Paclitaxel—ovarian cancer	0.00122	0.00956	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Paclitaxel—ovarian cancer	0.0012	0.00947	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Melphalan—ovarian cancer	0.0012	0.00943	CcSEcCtD
Chlorpromazine—CALM2—myometrium—ovarian cancer	0.00119	0.00899	CbGeAlD
Chlorpromazine—CALM1—myometrium—ovarian cancer	0.00118	0.00895	CbGeAlD
Chlorpromazine—Infection—Carboplatin—ovarian cancer	0.00118	0.00927	CcSEcCtD
Chlorpromazine—CALM3—uterine cervix—ovarian cancer	0.00118	0.00891	CbGeAlD
Chlorpromazine—CALM2—embryo—ovarian cancer	0.00114	0.00865	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00114	0.00898	CcSEcCtD
Chlorpromazine—CALM1—embryo—ovarian cancer	0.00114	0.00861	CbGeAlD
Chlorpromazine—Dizziness—Altretamine—ovarian cancer	0.00114	0.00893	CcSEcCtD
Chlorpromazine—CALM3—decidua—ovarian cancer	0.00112	0.00849	CbGeAlD
Chlorpromazine—SMPD1—lymph node—ovarian cancer	0.00111	0.00842	CbGeAlD
Chlorpromazine—KCNH2—myometrium—ovarian cancer	0.00108	0.00814	CbGeAlD
Chlorpromazine—CALM3—endometrium—ovarian cancer	0.00107	0.00806	CbGeAlD
Chlorpromazine—Cardiac arrest—Topotecan—ovarian cancer	0.00105	0.00827	CcSEcCtD
Chlorpromazine—HTR2B—uterine cervix—ovarian cancer	0.00105	0.00794	CbGeAlD
Chlorpromazine—Blood disorder—Paclitaxel—ovarian cancer	0.00105	0.00825	CcSEcCtD
Chlorpromazine—Throat sore—Docetaxel—ovarian cancer	0.00103	0.0081	CcSEcCtD
Chlorpromazine—Cardiac arrest—Melphalan—ovarian cancer	0.00103	0.00809	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Docetaxel—ovarian cancer	0.00102	0.00803	CcSEcCtD
Chlorpromazine—Pancytopenia—Chlorambucil—ovarian cancer	0.00102	0.00801	CcSEcCtD
Chlorpromazine—HTR2B—decidua—ovarian cancer	0.001	0.00757	CbGeAlD
Chlorpromazine—BCHE—myometrium—ovarian cancer	0.000991	0.0075	CbGeAlD
Chlorpromazine—CALM3—uterus—ovarian cancer	0.000982	0.00742	CbGeAlD
Chlorpromazine—Oropharyngeal pain—Paclitaxel—ovarian cancer	0.000963	0.00758	CcSEcCtD
Chlorpromazine—HTR2B—endometrium—ovarian cancer	0.00095	0.00719	CbGeAlD
Chlorpromazine—Body temperature increased—Carboplatin—ovarian cancer	0.000938	0.00738	CcSEcCtD
Chlorpromazine—CALM2—epithelium—ovarian cancer	0.000933	0.00706	CbGeAlD
Chlorpromazine—Jaundice—Chlorambucil—ovarian cancer	0.000933	0.00733	CcSEcCtD
Chlorpromazine—Dyskinesia—Paclitaxel—ovarian cancer	0.000932	0.00733	CcSEcCtD
Chlorpromazine—CALM1—epithelium—ovarian cancer	0.000929	0.00702	CbGeAlD
Chlorpromazine—CALM2—uterine cervix—ovarian cancer	0.000925	0.007	CbGeAlD
Chlorpromazine—CALM1—uterine cervix—ovarian cancer	0.000921	0.00696	CbGeAlD
Chlorpromazine—HTR7—epithelium—ovarian cancer	0.000908	0.00686	CbGeAlD
Chlorpromazine—Pancytopenia—Topotecan—ovarian cancer	0.000907	0.00714	CcSEcCtD
Chlorpromazine—Gait disturbance—Paclitaxel—ovarian cancer	0.000898	0.00706	CcSEcCtD
Chlorpromazine—Pancytopenia—Melphalan—ovarian cancer	0.000888	0.00699	CcSEcCtD
Chlorpromazine—CALM2—decidua—ovarian cancer	0.000882	0.00667	CbGeAlD
Chlorpromazine—CALM1—decidua—ovarian cancer	0.000878	0.00663	CbGeAlD
Chlorpromazine—HTR2B—uterus—ovarian cancer	0.000876	0.00662	CbGeAlD
Chlorpromazine—ADRA1A—epithelium—ovarian cancer	0.000875	0.00662	CbGeAlD
Chlorpromazine—HRH1—myometrium—ovarian cancer	0.000863	0.00653	CbGeAlD
Chlorpromazine—ADRA2A—myometrium—ovarian cancer	0.000848	0.00641	CbGeAlD
Chlorpromazine—Amenorrhoea—Docetaxel—ovarian cancer	0.000845	0.00665	CcSEcCtD
Chlorpromazine—KCNH2—uterine cervix—ovarian cancer	0.000838	0.00634	CbGeAlD
Chlorpromazine—HTR2C—female reproductive system—ovarian cancer	0.000838	0.00634	CbGeAlD
Chlorpromazine—CALM2—endometrium—ovarian cancer	0.000837	0.00633	CbGeAlD
Chlorpromazine—CALM3—bone marrow—ovarian cancer	0.000833	0.0063	CbGeAlD
Chlorpromazine—CALM1—endometrium—ovarian cancer	0.000833	0.0063	CbGeAlD
Chlorpromazine—Dysphagia—Vinorelbine—ovarian cancer	0.000817	0.00643	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Docetaxel—ovarian cancer	0.000817	0.00642	CcSEcCtD
Chlorpromazine—Jaundice—Melphalan—ovarian cancer	0.000813	0.00639	CcSEcCtD
Chlorpromazine—CALM3—female gonad—ovarian cancer	0.000803	0.00607	CbGeAlD
Chlorpromazine—CALM3—vagina—ovarian cancer	0.000798	0.00604	CbGeAlD
Chlorpromazine—CHRM1—female reproductive system—ovarian cancer	0.000791	0.00598	CbGeAlD
Chlorpromazine—HTR2B—female reproductive system—ovarian cancer	0.000787	0.00595	CbGeAlD
Chlorpromazine—CALM2—gonad—ovarian cancer	0.000776	0.00587	CbGeAlD
Chlorpromazine—Pancytopenia—Vinorelbine—ovarian cancer	0.000776	0.0061	CcSEcCtD
Chlorpromazine—CALM1—gonad—ovarian cancer	0.000773	0.00584	CbGeAlD
Chlorpromazine—SLC22A1—vagina—ovarian cancer	0.000772	0.00584	CbGeAlD
Chlorpromazine—BCHE—uterine cervix—ovarian cancer	0.000772	0.00583	CbGeAlD
Chlorpromazine—CALM2—uterus—ovarian cancer	0.000771	0.00583	CbGeAlD
Chlorpromazine—CALM1—uterus—ovarian cancer	0.000768	0.0058	CbGeAlD
Chlorpromazine—KCNH2—endometrium—ovarian cancer	0.000758	0.00573	CbGeAlD
Chlorpromazine—HTR7—gonad—ovarian cancer	0.000755	0.00571	CbGeAlD
Chlorpromazine—CALM3—testis—ovarian cancer	0.000713	0.00539	CbGeAlD
Chlorpromazine—HTR2B—vagina—ovarian cancer	0.000712	0.00538	CbGeAlD
Chlorpromazine—CHRM3—female reproductive system—ovarian cancer	0.000708	0.00535	CbGeAlD
Chlorpromazine—Tremor—Chlorambucil—ovarian cancer	0.000701	0.00551	CcSEcCtD
Chlorpromazine—KCNH2—uterus—ovarian cancer	0.000699	0.00528	CbGeAlD
Chlorpromazine—Nasal congestion—Paclitaxel—ovarian cancer	0.000698	0.00549	CcSEcCtD
Chlorpromazine—BCHE—endometrium—ovarian cancer	0.000698	0.00528	CbGeAlD
Chlorpromazine—HTR2A—embryo—ovarian cancer	0.000694	0.00524	CbGeAlD
Chlorpromazine—CALM2—female reproductive system—ovarian cancer	0.000693	0.00524	CbGeAlD
Chlorpromazine—CALM1—female reproductive system—ovarian cancer	0.00069	0.00522	CbGeAlD
Chlorpromazine—Angioedema—Chlorambucil—ovarian cancer	0.000683	0.00537	CcSEcCtD
Chlorpromazine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00068	0.00535	CcSEcCtD
Chlorpromazine—HRH1—epithelium—ovarian cancer	0.000678	0.00512	CbGeAlD
Chlorpromazine—HTR7—female reproductive system—ovarian cancer	0.000674	0.0051	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.000674	0.0053	CcSEcCtD
Chlorpromazine—HRH1—uterine cervix—ovarian cancer	0.000672	0.00508	CbGeAlD
Chlorpromazine—Leukopenia—Chlorambucil—ovarian cancer	0.000669	0.00526	CcSEcCtD
Chlorpromazine—ADRA2A—uterine cervix—ovarian cancer	0.00066	0.00499	CbGeAlD
Chlorpromazine—ALB—testis—ovarian cancer	0.00066	0.00499	CbGeAlD
Chlorpromazine—CALM2—bone marrow—ovarian cancer	0.000655	0.00495	CbGeAlD
Chlorpromazine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000652	0.00513	CcSEcCtD
Chlorpromazine—CALM1—bone marrow—ovarian cancer	0.000652	0.00493	CbGeAlD
Chlorpromazine—Convulsion—Chlorambucil—ovarian cancer	0.000648	0.0051	CcSEcCtD
Chlorpromazine—CHRM3—female gonad—ovarian cancer	0.000644	0.00487	CbGeAlD
Chlorpromazine—BCHE—uterus—ovarian cancer	0.000643	0.00486	CbGeAlD
Chlorpromazine—HRH1—decidua—ovarian cancer	0.00064	0.00484	CbGeAlD
Chlorpromazine—Muscle spasms—Topotecan—ovarian cancer	0.00064	0.00503	CcSEcCtD
Chlorpromazine—CALM2—female gonad—ovarian cancer	0.000631	0.00477	CbGeAlD
Chlorpromazine—ADRA2A—decidua—ovarian cancer	0.000629	0.00475	CbGeAlD
Chlorpromazine—KCNH2—female reproductive system—ovarian cancer	0.000628	0.00475	CbGeAlD
Chlorpromazine—CALM1—female gonad—ovarian cancer	0.000628	0.00475	CbGeAlD
Chlorpromazine—CALM2—vagina—ovarian cancer	0.000627	0.00474	CbGeAlD
Chlorpromazine—CALM1—vagina—ovarian cancer	0.000624	0.00472	CbGeAlD
Chlorpromazine—Glycosuria—Epirubicin—ovarian cancer	0.000618	0.00486	CcSEcCtD
Chlorpromazine—Angioedema—Topotecan—ovarian cancer	0.000608	0.00478	CcSEcCtD
Chlorpromazine—HRH1—endometrium—ovarian cancer	0.000608	0.00459	CbGeAlD
Chlorpromazine—Infection—Chlorambucil—ovarian cancer	0.000606	0.00477	CcSEcCtD
Chlorpromazine—Cardiac arrest—Paclitaxel—ovarian cancer	0.000605	0.00476	CcSEcCtD
Chlorpromazine—Blood disorder—Epirubicin—ovarian cancer	0.0006	0.00472	CcSEcCtD
Chlorpromazine—ADRA2A—endometrium—ovarian cancer	0.000597	0.00451	CbGeAlD
Chlorpromazine—Leukopenia—Topotecan—ovarian cancer	0.000596	0.00469	CcSEcCtD
Chlorpromazine—KCNH2—bone marrow—ovarian cancer	0.000593	0.00448	CbGeAlD
Chlorpromazine—Leukopenia—Melphalan—ovarian cancer	0.000583	0.00459	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.000581	0.00457	CcSEcCtD
Chlorpromazine—Cough—Topotecan—ovarian cancer	0.000581	0.00457	CcSEcCtD
Chlorpromazine—BCHE—female reproductive system—ovarian cancer	0.000578	0.00437	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—ovarian cancer	0.000572	0.0045	CcSEcCtD
Chlorpromazine—CHRM3—testis—ovarian cancer	0.000572	0.00432	CbGeAlD
Chlorpromazine—KCNH2—female gonad—ovarian cancer	0.000571	0.00432	CbGeAlD
Chlorpromazine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00057	0.00448	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—ovarian cancer	0.00057	0.00448	CcSEcCtD
Chlorpromazine—Cough—Melphalan—ovarian cancer	0.000569	0.00447	CcSEcCtD
Chlorpromazine—KCNH2—vagina—ovarian cancer	0.000568	0.00429	CbGeAlD
Chlorpromazine—HTR2A—epithelium—ovarian cancer	0.000566	0.00428	CbGeAlD
Chlorpromazine—Convulsion—Melphalan—ovarian cancer	0.000565	0.00444	CcSEcCtD
Chlorpromazine—CALM2—testis—ovarian cancer	0.00056	0.00423	CbGeAlD
Chlorpromazine—CALM1—testis—ovarian cancer	0.000557	0.00421	CbGeAlD
Chlorpromazine—Blood disorder—Doxorubicin—ovarian cancer	0.000555	0.00436	CcSEcCtD
Chlorpromazine—ADRA2A—gonad—ovarian cancer	0.000554	0.00419	CbGeAlD
Chlorpromazine—ADRA2A—uterus—ovarian cancer	0.00055	0.00416	CbGeAlD
Chlorpromazine—Influenza—Paclitaxel—ovarian cancer	0.00055	0.00432	CcSEcCtD
Chlorpromazine—Dysphagia—Paclitaxel—ovarian cancer	0.00055	0.00432	CcSEcCtD
Chlorpromazine—BCHE—bone marrow—ovarian cancer	0.000546	0.00413	CbGeAlD
Chlorpromazine—HTR7—testis—ovarian cancer	0.000544	0.00411	CbGeAlD
Chlorpromazine—Anaphylactic shock—Topotecan—ovarian cancer	0.000543	0.00427	CcSEcCtD
Chlorpromazine—Infection—Topotecan—ovarian cancer	0.00054	0.00424	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—ovarian cancer	0.000533	0.00419	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Melphalan—ovarian cancer	0.000532	0.00418	CcSEcCtD
Chlorpromazine—Infection—Melphalan—ovarian cancer	0.000528	0.00416	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—ovarian cancer	0.000527	0.00415	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000527	0.00415	CcSEcCtD
Chlorpromazine—BCHE—vagina—ovarian cancer	0.000523	0.00395	CbGeAlD
Chlorpromazine—Pancytopenia—Paclitaxel—ovarian cancer	0.000522	0.00411	CcSEcCtD
Chlorpromazine—Angioedema—Vinorelbine—ovarian cancer	0.00052	0.00409	CcSEcCtD
Chlorpromazine—Tachycardia—Melphalan—ovarian cancer	0.000519	0.00408	CcSEcCtD
Chlorpromazine—CALM3—lymph node—ovarian cancer	0.000516	0.0039	CbGeAlD
Chlorpromazine—DRD2—testis—ovarian cancer	0.000514	0.00389	CbGeAlD
Chlorpromazine—Gait disturbance—Epirubicin—ovarian cancer	0.000513	0.00404	CcSEcCtD
Chlorpromazine—Leukopenia—Vinorelbine—ovarian cancer	0.00051	0.00401	CcSEcCtD
Chlorpromazine—KCNH2—testis—ovarian cancer	0.000507	0.00383	CbGeAlD
Chlorpromazine—HRH1—female reproductive system—ovarian cancer	0.000503	0.00381	CbGeAlD
Chlorpromazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.000502	0.00395	CcSEcCtD
Chlorpromazine—Hypotension—Melphalan—ovarian cancer	0.000497	0.00391	CcSEcCtD
Chlorpromazine—Cough—Vinorelbine—ovarian cancer	0.000497	0.00391	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000496	0.0039	CcSEcCtD
Chlorpromazine—Dermatitis contact—Epirubicin—ovarian cancer	0.000495	0.00389	CcSEcCtD
Chlorpromazine—ADRA2A—female reproductive system—ovarian cancer	0.000494	0.00374	CbGeAlD
Chlorpromazine—Dyskinesia—Doxorubicin—ovarian cancer	0.000493	0.00388	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.000492	0.00387	CcSEcCtD
Chlorpromazine—Dyspnoea—Topotecan—ovarian cancer	0.000484	0.00381	CcSEcCtD
Chlorpromazine—CYP2E1—female reproductive system—ovarian cancer	0.000484	0.00366	CbGeAlD
Chlorpromazine—Body temperature increased—Chlorambucil—ovarian cancer	0.000482	0.00379	CcSEcCtD
Chlorpromazine—ALB—lymph node—ovarian cancer	0.000478	0.00362	CbGeAlD
Chlorpromazine—Gait disturbance—Doxorubicin—ovarian cancer	0.000475	0.00373	CcSEcCtD
Chlorpromazine—Dyspnoea—Melphalan—ovarian cancer	0.000474	0.00373	CcSEcCtD
Chlorpromazine—ABCB1—myometrium—ovarian cancer	0.000473	0.00357	CbGeAlD
Chlorpromazine—HTR2A—gonad—ovarian cancer	0.000471	0.00356	CbGeAlD
Chlorpromazine—Aplastic anaemia—Epirubicin—ovarian cancer	0.00047	0.0037	CcSEcCtD
Chlorpromazine—BCHE—testis—ovarian cancer	0.000467	0.00353	CbGeAlD
Chlorpromazine—Dysphagia—Docetaxel—ovarian cancer	0.000466	0.00366	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000465	0.00365	CcSEcCtD
Chlorpromazine—Constipation—Topotecan—ovarian cancer	0.000465	0.00365	CcSEcCtD
Chlorpromazine—Infection—Vinorelbine—ovarian cancer	0.000462	0.00363	CcSEcCtD
Chlorpromazine—HTR2B—lymph node—ovarian cancer	0.000461	0.00348	CbGeAlD
Chlorpromazine—HRH1—female gonad—ovarian cancer	0.000458	0.00346	CbGeAlD
Chlorpromazine—Dermatitis contact—Doxorubicin—ovarian cancer	0.000458	0.0036	CcSEcCtD
Chlorpromazine—HRH1—vagina—ovarian cancer	0.000455	0.00344	CbGeAlD
Chlorpromazine—ABCB1—embryo—ovarian cancer	0.000454	0.00344	CbGeAlD
Chlorpromazine—Tachycardia—Vinorelbine—ovarian cancer	0.000454	0.00357	CcSEcCtD
Chlorpromazine—ADRA2A—female gonad—ovarian cancer	0.00045	0.0034	CbGeAlD
Chlorpromazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00045	0.00354	CcSEcCtD
Chlorpromazine—ADRA2A—vagina—ovarian cancer	0.000447	0.00338	CbGeAlD
Chlorpromazine—Pancytopenia—Docetaxel—ovarian cancer	0.000442	0.00348	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000435	0.00342	CcSEcCtD
Chlorpromazine—Hypotension—Vinorelbine—ovarian cancer	0.000434	0.00342	CcSEcCtD
Chlorpromazine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000433	0.00341	CcSEcCtD
Chlorpromazine—Body temperature increased—Topotecan—ovarian cancer	0.000429	0.00338	CcSEcCtD
Chlorpromazine—Visual impairment—Paclitaxel—ovarian cancer	0.000424	0.00333	CcSEcCtD
Chlorpromazine—HTR2A—female reproductive system—ovarian cancer	0.00042	0.00318	CbGeAlD
Chlorpromazine—Dyspnoea—Vinorelbine—ovarian cancer	0.000414	0.00326	CcSEcCtD
Chlorpromazine—Photosensitivity—Epirubicin—ovarian cancer	0.000414	0.00326	CcSEcCtD
Chlorpromazine—HRH1—testis—ovarian cancer	0.000406	0.00307	CbGeAlD
Chlorpromazine—CALM2—lymph node—ovarian cancer	0.000406	0.00307	CbGeAlD
Chlorpromazine—Jaundice—Docetaxel—ovarian cancer	0.000405	0.00318	CcSEcCtD
Chlorpromazine—CALM1—lymph node—ovarian cancer	0.000404	0.00305	CbGeAlD
Chlorpromazine—Hypersensitivity—Topotecan—ovarian cancer	0.0004	0.00315	CcSEcCtD
Chlorpromazine—ADRA2A—testis—ovarian cancer	0.000399	0.00302	CbGeAlD
Chlorpromazine—Constipation—Vinorelbine—ovarian cancer	0.000397	0.00313	CcSEcCtD
Chlorpromazine—Hypersensitivity—Melphalan—ovarian cancer	0.000392	0.00308	CcSEcCtD
Chlorpromazine—CYP2E1—testis—ovarian cancer	0.00039	0.00295	CbGeAlD
Chlorpromazine—CYP3A4—female reproductive system—ovarian cancer	0.000389	0.00294	CbGeAlD
Chlorpromazine—Agranulocytosis—Docetaxel—ovarian cancer	0.000388	0.00305	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000385	0.00303	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—ovarian cancer	0.000383	0.00301	CcSEcCtD
Chlorpromazine—CYP2D6—female reproductive system—ovarian cancer	0.000383	0.0029	CbGeAlD
Chlorpromazine—HTR2A—vagina—ovarian cancer	0.00038	0.00287	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000376	0.00295	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000373	0.00293	CcSEcCtD
Chlorpromazine—Nervousness—Paclitaxel—ovarian cancer	0.000372	0.00293	CcSEcCtD
Chlorpromazine—ABCB1—epithelium—ovarian cancer	0.000371	0.0028	CbGeAlD
Chlorpromazine—Muscle spasms—Paclitaxel—ovarian cancer	0.000368	0.0029	CcSEcCtD
Chlorpromazine—ABCB1—uterine cervix—ovarian cancer	0.000368	0.00278	CbGeAlD
Chlorpromazine—KCNH2—lymph node—ovarian cancer	0.000367	0.00278	CbGeAlD
Chlorpromazine—Body temperature increased—Vinorelbine—ovarian cancer	0.000367	0.00289	CcSEcCtD
Chlorpromazine—Oedema peripheral—Docetaxel—ovarian cancer	0.000367	0.00289	CcSEcCtD
Chlorpromazine—Visual impairment—Docetaxel—ovarian cancer	0.000359	0.00283	CcSEcCtD
Chlorpromazine—Dizziness—Topotecan—ovarian cancer	0.000359	0.00283	CcSEcCtD
Chlorpromazine—Tremor—Paclitaxel—ovarian cancer	0.000359	0.00282	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000357	0.0028	CcSEcCtD
Chlorpromazine—ABCB1—decidua—ovarian cancer	0.00035	0.00265	CbGeAlD
Chlorpromazine—Angioedema—Paclitaxel—ovarian cancer	0.00035	0.00275	CcSEcCtD
Chlorpromazine—CYP2D6—female gonad—ovarian cancer	0.000349	0.00263	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000348	0.00273	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—ovarian cancer	0.000346	0.00272	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000345	0.00271	CcSEcCtD
Chlorpromazine—Syncope—Paclitaxel—ovarian cancer	0.000343	0.0027	CcSEcCtD
Chlorpromazine—Leukopenia—Paclitaxel—ovarian cancer	0.000343	0.0027	CcSEcCtD
Chlorpromazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000342	0.00269	CcSEcCtD
Chlorpromazine—HTR2A—testis—ovarian cancer	0.000339	0.00257	CbGeAlD
Chlorpromazine—BCHE—lymph node—ovarian cancer	0.000338	0.00256	CbGeAlD
Chlorpromazine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000337	0.00265	CcSEcCtD
Chlorpromazine—Cough—Paclitaxel—ovarian cancer	0.000334	0.00263	CcSEcCtD
Chlorpromazine—ABCB1—endometrium—ovarian cancer	0.000333	0.00251	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000332	0.00261	CcSEcCtD
Chlorpromazine—Convulsion—Paclitaxel—ovarian cancer	0.000332	0.00261	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00032	0.00252	CcSEcCtD
Chlorpromazine—Dry mouth—Paclitaxel—ovarian cancer	0.000319	0.00251	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—ovarian cancer	0.000314	0.00247	CcSEcCtD
Chlorpromazine—Dysphagia—Epirubicin—ovarian cancer	0.000314	0.00247	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—ovarian cancer	0.000314	0.00247	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000313	0.00246	CcSEcCtD
Chlorpromazine—Muscle spasms—Docetaxel—ovarian cancer	0.000312	0.00245	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—ovarian cancer	0.000311	0.00245	CcSEcCtD
Chlorpromazine—Infection—Paclitaxel—ovarian cancer	0.000311	0.00244	CcSEcCtD
Chlorpromazine—CYP2D6—testis—ovarian cancer	0.000309	0.00234	CbGeAlD
Chlorpromazine—ABCB1—gonad—ovarian cancer	0.000308	0.00233	CbGeAlD
Chlorpromazine—Shock—Paclitaxel—ovarian cancer	0.000308	0.00242	CcSEcCtD
Chlorpromazine—Dizziness—Vinorelbine—ovarian cancer	0.000307	0.00242	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000307	0.00242	CcSEcCtD
Chlorpromazine—ABCB1—uterus—ovarian cancer	0.000306	0.00232	CbGeAlD
Chlorpromazine—Tachycardia—Paclitaxel—ovarian cancer	0.000305	0.0024	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—ovarian cancer	0.000298	0.00235	CcSEcCtD
Chlorpromazine—HRH1—lymph node—ovarian cancer	0.000294	0.00223	CbGeAlD
Chlorpromazine—Hypotension—Paclitaxel—ovarian cancer	0.000292	0.0023	CcSEcCtD
Chlorpromazine—Syncope—Docetaxel—ovarian cancer	0.000291	0.00229	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—ovarian cancer	0.000291	0.00229	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—ovarian cancer	0.000291	0.00229	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—ovarian cancer	0.000291	0.00229	CcSEcCtD
Chlorpromazine—Leukopenia—Docetaxel—ovarian cancer	0.000291	0.00229	CcSEcCtD
Chlorpromazine—ADRA2A—lymph node—ovarian cancer	0.000289	0.00219	CbGeAlD
Chlorpromazine—Eosinophilia—Doxorubicin—ovarian cancer	0.000288	0.00226	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000287	0.00226	CcSEcCtD
Chlorpromazine—Loss of consciousness—Docetaxel—ovarian cancer	0.000285	0.00224	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000283	0.00223	CcSEcCtD
Chlorpromazine—Cough—Docetaxel—ovarian cancer	0.000283	0.00223	CcSEcCtD
Chlorpromazine—Insomnia—Paclitaxel—ovarian cancer	0.000283	0.00222	CcSEcCtD
Chlorpromazine—Convulsion—Docetaxel—ovarian cancer	0.000281	0.00221	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—ovarian cancer	0.00028	0.0022	CcSEcCtD
Chlorpromazine—Dyspnoea—Paclitaxel—ovarian cancer	0.000279	0.00219	CcSEcCtD
Chlorpromazine—Somnolence—Paclitaxel—ovarian cancer	0.000278	0.00219	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000276	0.00217	CcSEcCtD
Chlorpromazine—ABCB1—female reproductive system—ovarian cancer	0.000276	0.00208	CbGeAlD
Chlorpromazine—Jaundice—Epirubicin—ovarian cancer	0.000273	0.00215	CcSEcCtD
Chlorpromazine—Dry mouth—Docetaxel—ovarian cancer	0.00027	0.00213	CcSEcCtD
Chlorpromazine—Constipation—Paclitaxel—ovarian cancer	0.000267	0.0021	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000265	0.00209	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000265	0.00208	CcSEcCtD
Chlorpromazine—Infection—Docetaxel—ovarian cancer	0.000263	0.00207	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000262	0.00206	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000261	0.00206	CcSEcCtD
Chlorpromazine—Shock—Docetaxel—ovarian cancer	0.000261	0.00205	CcSEcCtD
Chlorpromazine—ABCB1—bone marrow—ovarian cancer	0.00026	0.00197	CbGeAlD
Chlorpromazine—Drowsiness—Doxorubicin—ovarian cancer	0.000259	0.00204	CcSEcCtD
Chlorpromazine—Tachycardia—Docetaxel—ovarian cancer	0.000259	0.00203	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—ovarian cancer	0.000253	0.00199	CcSEcCtD
Chlorpromazine—ABCB1—female gonad—ovarian cancer	0.000251	0.0019	CbGeAlD
Chlorpromazine—ABCB1—vagina—ovarian cancer	0.000249	0.00188	CbGeAlD
Chlorpromazine—Oedema peripheral—Epirubicin—ovarian cancer	0.000248	0.00195	CcSEcCtD
Chlorpromazine—Hypotension—Docetaxel—ovarian cancer	0.000248	0.00195	CcSEcCtD
Chlorpromazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000247	0.00194	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—ovarian cancer	0.000242	0.00191	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000242	0.0019	CcSEcCtD
Chlorpromazine—Insomnia—Docetaxel—ovarian cancer	0.00024	0.00188	CcSEcCtD
Chlorpromazine—Dyspnoea—Docetaxel—ovarian cancer	0.000236	0.00186	CcSEcCtD
Chlorpromazine—Somnolence—Docetaxel—ovarian cancer	0.000236	0.00185	CcSEcCtD
Chlorpromazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00023	0.00181	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000229	0.0018	CcSEcCtD
Chlorpromazine—Constipation—Docetaxel—ovarian cancer	0.000227	0.00178	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—ovarian cancer	0.000224	0.00176	CcSEcCtD
Chlorpromazine—ABCB1—testis—ovarian cancer	0.000222	0.00168	CbGeAlD
Chlorpromazine—Nervousness—Epirubicin—ovarian cancer	0.000213	0.00167	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—ovarian cancer	0.000211	0.00166	CcSEcCtD
Chlorpromazine—Body temperature increased—Docetaxel—ovarian cancer	0.000209	0.00165	CcSEcCtD
Chlorpromazine—Dizziness—Paclitaxel—ovarian cancer	0.000207	0.00163	CcSEcCtD
Chlorpromazine—Nervousness—Doxorubicin—ovarian cancer	0.000197	0.00155	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—ovarian cancer	0.000196	0.00154	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—ovarian cancer	0.000196	0.00154	CcSEcCtD
Chlorpromazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000195	0.00154	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000195	0.00153	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—ovarian cancer	0.000192	0.00151	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—ovarian cancer	0.000191	0.0015	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—ovarian cancer	0.00019	0.00149	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—ovarian cancer	0.000182	0.00143	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—ovarian cancer	0.000182	0.00143	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—ovarian cancer	0.000181	0.00143	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000179	0.00141	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000178	0.0014	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—ovarian cancer	0.000178	0.0014	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—ovarian cancer	0.000177	0.00139	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—ovarian cancer	0.000176	0.00138	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—ovarian cancer	0.000176	0.00138	CcSEcCtD
Chlorpromazine—Dizziness—Docetaxel—ovarian cancer	0.000175	0.00138	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—ovarian cancer	0.000174	0.00137	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—ovarian cancer	0.000169	0.00133	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—ovarian cancer	0.000167	0.00131	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000165	0.0013	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—ovarian cancer	0.000164	0.00129	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—ovarian cancer	0.000163	0.00128	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—ovarian cancer	0.000162	0.00127	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—ovarian cancer	0.000161	0.00127	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—ovarian cancer	0.000161	0.00122	CbGeAlD
Chlorpromazine—Dyspnoea—Epirubicin—ovarian cancer	0.000159	0.00125	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—ovarian cancer	0.000159	0.00125	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—ovarian cancer	0.000155	0.00122	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—ovarian cancer	0.000153	0.0012	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—ovarian cancer	0.00015	0.00118	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000147	0.00116	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—ovarian cancer	0.000147	0.00116	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—ovarian cancer	0.000141	0.00111	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—ovarian cancer	0.000141	0.00111	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000132	0.00104	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000131	0.00103	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000122	0.000958	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—ovarian cancer	0.000118	0.000929	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—ovarian cancer	0.000109	0.00086	CcSEcCtD
Chlorpromazine—Diltiazem—ABCB1—ovarian cancer	0.0001	0.128	CrCbGaD
Chlorpromazine—Triflupromazine—ABCB1—ovarian cancer	8.92e-05	0.114	CrCbGaD
Chlorpromazine—Clobazam—ABCB1—ovarian cancer	7.94e-05	0.102	CrCbGaD
Chlorpromazine—Fluphenazine—ABCB1—ovarian cancer	6.86e-05	0.0877	CrCbGaD
Chlorpromazine—Clomipramine—ABCB1—ovarian cancer	6.27e-05	0.0802	CrCbGaD
Chlorpromazine—Chlorprothixene—ABCB1—ovarian cancer	6.25e-05	0.0799	CrCbGaD
Chlorpromazine—Flurazepam—ABCB1—ovarian cancer	5.83e-05	0.0746	CrCbGaD
Chlorpromazine—Trimipramine—ABCB1—ovarian cancer	5.77e-05	0.0738	CrCbGaD
Chlorpromazine—Promethazine—ABCB1—ovarian cancer	5.56e-05	0.0711	CrCbGaD
Chlorpromazine—Trifluoperazine—ABCB1—ovarian cancer	5.48e-05	0.0701	CrCbGaD
Chlorpromazine—Desipramine—ABCB1—ovarian cancer	5.05e-05	0.0646	CrCbGaD
Chlorpromazine—Imipramine—ABCB1—ovarian cancer	4.28e-05	0.0548	CrCbGaD
Chlorpromazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	4.38e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.38e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	4.37e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.36e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	4.36e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	4.35e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	4.35e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	4.35e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—ovarian cancer	4.35e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL2—ovarian cancer	4.34e-06	2.4e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—ovarian cancer	4.33e-06	2.4e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—ovarian cancer	4.33e-06	2.4e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—ovarian cancer	4.32e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.32e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—IL6—ovarian cancer	4.32e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—ovarian cancer	4.31e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—ovarian cancer	4.31e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.31e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	4.31e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	4.3e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	4.29e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	4.29e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.29e-06	2.37e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.27e-06	2.37e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—ovarian cancer	4.27e-06	2.36e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—ovarian cancer	4.24e-06	2.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—ovarian cancer	4.23e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—ovarian cancer	4.23e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—ovarian cancer	4.21e-06	2.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—ovarian cancer	4.21e-06	2.33e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.21e-06	2.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL2—ovarian cancer	4.2e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL2—ovarian cancer	4.2e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	4.2e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	4.19e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.18e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—IL6—ovarian cancer	4.18e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—IL6—ovarian cancer	4.18e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	4.17e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	4.17e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—ovarian cancer	4.16e-06	2.3e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IL6—ovarian cancer	4.14e-06	2.29e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.13e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—ovarian cancer	4.12e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.12e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—ovarian cancer	4.12e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—ovarian cancer	4.12e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—ovarian cancer	4.11e-06	2.27e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—ovarian cancer	4.09e-06	2.27e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—ovarian cancer	4.09e-06	2.27e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.09e-06	2.26e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—ovarian cancer	4.09e-06	2.26e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IL6—ovarian cancer	4.08e-06	2.26e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—ovarian cancer	4.08e-06	2.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.07e-06	2.25e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.07e-06	2.25e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.07e-06	2.25e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—ovarian cancer	4.06e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	4.05e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	4.05e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—ovarian cancer	4.05e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	4.04e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.04e-06	2.23e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	4.02e-06	2.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—ovarian cancer	4.02e-06	2.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	4e-06	2.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	4e-06	2.22e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	4e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—ovarian cancer	3.98e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	3.97e-06	2.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	3.97e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—ovarian cancer	3.95e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—ovarian cancer	3.95e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL6—ovarian cancer	3.95e-06	2.18e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	3.93e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	3.93e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.92e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	3.92e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	3.92e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—ovarian cancer	3.89e-06	2.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—ovarian cancer	3.87e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	3.86e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	3.86e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	3.84e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	3.83e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	3.83e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL6—ovarian cancer	3.82e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL6—ovarian cancer	3.82e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—ovarian cancer	3.82e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—ovarian cancer	3.81e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CAV1—ovarian cancer	3.78e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	3.78e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	3.78e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	3.77e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—ovarian cancer	3.77e-06	2.08e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	3.76e-06	2.08e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	3.75e-06	2.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	3.72e-06	2.06e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	3.72e-06	2.06e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	3.71e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—ovarian cancer	3.7e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	3.7e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	3.7e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	3.7e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	3.69e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—ovarian cancer	3.68e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—ovarian cancer	3.68e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STAT3—ovarian cancer	3.65e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRAS—ovarian cancer	3.65e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—IL6—ovarian cancer	3.64e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—ovarian cancer	3.64e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—ovarian cancer	3.64e-06	2.01e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	3.64e-06	2.01e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	3.64e-06	2.01e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	3.57e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	3.57e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IL6—ovarian cancer	3.56e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	3.54e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IL6—ovarian cancer	3.54e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STAT3—ovarian cancer	3.53e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STAT3—ovarian cancer	3.53e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.53e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRAS—ovarian cancer	3.53e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRAS—ovarian cancer	3.53e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—IL6—ovarian cancer	3.53e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—IL6—ovarian cancer	3.53e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—ovarian cancer	3.52e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—ovarian cancer	3.52e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	3.49e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—ovarian cancer	3.49e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.47e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.47e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	3.46e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.45e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—ovarian cancer	3.45e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.45e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	3.44e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	3.44e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.42e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—ovarian cancer	3.41e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.41e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	3.4e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—ovarian cancer	3.4e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	3.39e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	3.38e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	3.38e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—ovarian cancer	3.36e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—ovarian cancer	3.36e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.36e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—ovarian cancer	3.35e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.34e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—ovarian cancer	3.33e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—ovarian cancer	3.33e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—ovarian cancer	3.33e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	3.32e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—ovarian cancer	3.32e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.3e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.29e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—ovarian cancer	3.28e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—ovarian cancer	3.28e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	3.28e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	3.27e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.26e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—ovarian cancer	3.25e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—ovarian cancer	3.25e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	3.21e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	3.21e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—ovarian cancer	3.21e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—ovarian cancer	3.21e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.21e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	3.21e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.2e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	3.19e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	3.16e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.15e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.15e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—ovarian cancer	3.14e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	3.13e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL6—ovarian cancer	3.12e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—ovarian cancer	3.09e-06	1.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.07e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL6—ovarian cancer	3.07e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.06e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	3.06e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL6—ovarian cancer	3.05e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—ovarian cancer	3.03e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—ovarian cancer	3.03e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.03e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL6—ovarian cancer	3.02e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	3.01e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—ovarian cancer	2.98e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—ovarian cancer	2.96e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	2.92e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	2.88e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	2.88e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.84e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—ovarian cancer	2.83e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	2.83e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	2.82e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—ovarian cancer	2.82e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	2.81e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	2.8e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—ovarian cancer	2.79e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	2.79e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	2.79e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	2.78e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	2.78e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—ovarian cancer	2.72e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—ovarian cancer	2.72e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—ovarian cancer	2.7e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—ovarian cancer	2.7e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—ovarian cancer	2.67e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.64e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.61e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	2.58e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—ovarian cancer	2.58e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—ovarian cancer	2.58e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL6—ovarian cancer	2.55e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL6—ovarian cancer	2.47e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL6—ovarian cancer	2.47e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.46e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—ovarian cancer	2.44e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—ovarian cancer	2.35e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.28e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—ovarian cancer	2.28e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—ovarian cancer	2.28e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—ovarian cancer	2.13e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.09e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—ovarian cancer	2.01e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.7e-06	9.43e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.61e-06	8.91e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.31e-06	7.28e-06	CbGpPWpGaD
